Johnson & Johnson and Guidant Hold More Talks on Acquisition
693727
Johnson & Johnson, the health care conglomerate, continued its acquisition talks with Guidant, one of the nation's largest makers of devices to treat heart and circulatory illnesses.
739833
U.S. blue chips rose  on Thursday,  boosted by Johnson & Johnson JNJ.N following its move to buy  Guidant Corp. GDT.N, but market gains were limited after  Goldman Sachs posted disappointing revenues.
202527
Johnson &amp; Johnson has made a deal to buy Guidant Corp. a producer of medical equipment for patients with heart and circulatory illnesses, for $24 billion in stock and cash.
455781
It has been a long and tortured courtship. For years, health-care giant Johnson &amp; Johnson (JNJ ) has held on-again, off-again acquisition talks with medical-device maker Guidant (GDT ). Now Wall Street sources say the companies are talking again.
478171
INDIANAPOLIS - Health care products giant Johnson &amp; Johnson&#39;s $25.4 billion acquisition of Guidant Corp., formally announced Thursday, could face a tough review from regulators because of their competition in the coronary stent market, analysts say.
214525
U.S. stocks were slightly higher on  Tuesday, with lower oil prices helping support markets, but  Johnson & Johnson JNJ.N dragged on the Dow following a report  of a possible $24 billion takeover of cardiovascular device  maker Guidant Corp. GDT.N.
565121
Johnson & Johnson, the pharmaceutical and health care giant, is near a deal to buy Guidant, one of the nation's largest makers of devices to treat heart and circulatory illnesses.
179502
Shares of medical device maker Guidant  Corp.GDT.N jumped on Tuesday after a report saying the  company was in advanced talks to be acquired by health products  maker Johnson & Johnson JNJ.N for more than $24 billion.
499783
Oracle Corp has reiterated that its stalled merger with PeopleSoft Inc is not the only acquisition opportunity it is considering, and said that talks with other potential targets are already in progress.
21679
The anticipated merger of Guidant Corp.  and Johnson & Johnson could give an unintended boost to Boston  Scientific Corp. if Guidant's drug-coated stent launch is  delayed, said analysts looking at the implications of a  potential deal.
466964
NEW YORK Johnson &amp; Johnson is in advanced negotiations to acquire Guidant, one of the largest US makers of devices to treat heart and circulatory illnesses, according to executives close to the talks.
59122
Stocks looked to open slightly higher  on Tuesday, with Wall Street welcoming a slip in oil prices and  news of a possible merger between Johnson & Johnson JNJ.N and  cardiovascular device maker Guidant Corp. GDT.N.
478256
U.S. blue chips moved higher  on  Thursday, getting a lift from Johnson & Johnson JNJ.N  following its acquisition of medical device maker Guidant Corp.  GDT.N, but broader market gains were capped after investment  bank Goldman Sachs posted disappointing quarterly revenues.
541643
The General Electric Company and Pearson are exploring a joint bid for Dow Jones & Company, people familiar with the talks said.
360773
Johnson &amp; Johnson, whose board is meeting today, is close to agreeing to pay $24 billion for Guidant Corp., the world&#39;s second-biggest maker of heart-rhythm devices, people familiar with the matter said.
312138
U.S. stocks were little changed on  Tuesday, with lower oil prices helping support markets, but  Johnson & Johnson JNJ.N dragged on the Dow following a report  of a possible $24 billion takeover of cardiovascular device  maker Guidant Corp. GDT.N.
497700
NEW YORK -- Johnson &amp; Johnson, the New Jersey-based drug and health care products company, is reportedly in advanced negotiations to buy Guidant Corp.